Immunoassays: Technologies and Global Markets

Report Code: BIO033C

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global immunoassay tests market reached $30.6 billion in 2022 and should reach $39.8 billion by 2027, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2022-2027.

Report Includes

  • 124 data tables and 4 additional tables
  • An up-to-date review and analysis of the global markets for immunoassays and related technologies
  • Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for global immunoassays market in USD millions, and corresponding market share analysis based on product type, application, and region
  • Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors affecting the market for immunoassays as a basis for projecting demand over the next few years (2022-2027)
  • Insight into prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent breakthrough innovations, clinical trials, and value chain analyses
  • Assessment of the recent industry structure for microbiome therapeutics, ongoing research (R&D) activities, analysis of the competitive environment, and COVID-19 impact on the biotech industry
  • Review of the patents and patent applications on immunoassays testing and applications
  • Competitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial performances, and market share analysis based on recent segmental revenues
  • Company profiles of major players within the industry, including Abbott Laboratories, Biomerieux S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific

Report Scope

The report is designed to be a comprehensive business tool to provide an in-depth look at the market for immunoassays. The geographic scope of the report is global. The report reviews each type of immunoassay and reviews technologies associated with immunoassays and equipment. The report also explores market size, identifies market participants and investigates patents in the immunoassays market.

The global market for immunoassays is divided into categories by immunoassay type and by application as follows.

By product:

  • Enzyme immunoassays.
  • Fluorescent immunoassays.
  • Radioimmunoassays.
  • Chemiluminescent immunoassays.
  • Lateral flow immunoassays and multiplex immunoassays.

By application:

  • Diabetes.
  • Drug screening.
  • Infectious diseases.
  • Cancer.
  • Cardiology.
  • Reproductive.
  • Other immunoassays.

Each area is covered in detail, identifying current products in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $29 billion
Market size forecast $39.8 billion
Growth rate CAGR of 5.4% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Region, Type of Test, Application
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, Japan, China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, Indonesia, Middle East, Africa, South America
Key Market Drivers
  • Global Burden of Disease
  • Aging Population
Companies studied
Company ProfilesABBOTT
ABCAM LTD.BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIOMERIEUXBIO-RAD LABORATORIES INC.
DIASORIN S.P.A.MERCK & CO. INC.
MINDRAYORASURE TECHNOLOGIES
PERKINELMER INC.QUIDELORTHO CORP.
RANDOX LABORATORIES LTD.F. HOFFMANN-LA ROCHE LTD.
SD BIOSENSORSIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The immunoassays: technologies and global market is projected to grow from $29.0 billion in 2021 to $39.8 billion in 2027, at a compound annual growth rate (CAGR) of 5.4% during the forecast period.
The key factors driving the growth of immunoassays market is majorly driven by the rising chronic disease such as cancer, diabetes, autoimmune diseases, cardiovascular diseases and infectious diseases such as influenza, HIV, tuberculosis, including COVID-19, technological advancements in immunoassays development, increasing use of immunoassays in oncology due to its specificity in detecting presence of tumour antigens and application of immunoassays in drug discovery and development including toxicology studies, identifying drug responsive biomarkers are the key factors propelling the growth of this market.
The immunoassays: technologies and global market is segmented based on the product type such as EIA, radioimmunoassay, FIA, CLIA, LFI’s & MIA’s by application includes diabetes, infectious disease, drug screening, cancer, cardiology, reproductive, other-immunoassays and by geographic region.
LFI’s & MIA’s will dominate the market by the end of 2027.
Key companies in the market includes Roche Diagnostics, Abbott, Siemens Healthineers, Danaher, Thermofisher-Scientific, Diasorin, bioMérieux, etc.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Immunoassays: Technologies and Global Markets127Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview5Free
Chapter- 4: Market Dynamics4Free
Chapter- 5: Impact of the COVID-19 Pandemic3Free
Chapter- 6: Global Market for Immunoassays4Free
Chapter- 7: Market Breakdown by Type of Test25Free
Chapter- 8: Market Breakdown by Application36Free
Chapter- 9: Competitive Landscape12Free
Chapter- 10: Patents2Free
Chapter- 11: Company Profiles23Free
Chapter- 12: Appendix: Acronyms1Free
Published - Apr-2013| Analyst - Carlet Auguste| Code - BIO033B

Report Highlights

The global demand for immunoassay testing was nearly $15.6 billion in 2011 and $16.3 billion in 2012. This market is expected to grow to $20.5 billion by 2017, at a compound annual growth rate (CAGR) of 4.7% from 2012 to 2017.

Report Includes

  • An overview of the global market for growth of immunoassay technology in clinical, food safety, and environmental areas.
  • Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017.
  • Discussion of government regulations and technology patents and the roles they play in development.
  • Analysis of new markets.
  • Comprehensive company profiles of major players.
Published - Dec-2001| Analyst - Ruth Scolnick| Code - BIO033A

Report Highlights

  • As the human genome-sequencing project nears completion and other organisms' genomes are sequenced, the number of known proteins increases. Many proteins are currently being used and will be used as diagnostic tools in immunoassays. Immunoassays are used in a variety of applications: medical diagnostics, infectious disease testing, drug testing, home use, hormones, veterinary diagnostic, cancer, tissue typing, research, food testing, environmental testing, industrial chemicals, plant disease diagnostics, and biotechnology products testing. Enzyme-linked immunosorbent, chemiluminescent, fluorescent, radio-labeled, and immunoprecipitation are some of the old and new immunoassay technologies being used. New immunoassay technologies are also being developed. Since the number of known proteins and the potential number of immunoassays are increasing, it is interesting to analyze the current and developing immunoassay technologies and markets.
  • This report is an analytical tool whose primary purpose is to show increased growth in the current and emerging clinical, food safety, and environmental immunoassay fields. The report discusses specific, patented technology, the role of government regulation and patents that affect the development and growth of the various immunoassay markets.

Related Reports

Plastics in Electronics Components: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - PLS027F

The global plastics used in electronic components market reached $7.9 billion in 2022 and should reach $10.3 billion by 2027, with a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2022-2027.

In Vitro Diagnostics: Technologies and Global Markets

Published - May 2021 | Publisher - Jon Evans | Code - HLC186C

The global market for in vitro diagnostics (IVD) should increase from $74.1 billion in 2020 to reach $102.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.7% during the period of 2020-2025.

Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases

Published - Oct 2020 | Publisher - BCC Publishing | Code - PHM005E

The global market for sexually transmitted disease diagnostics should grow from $7.6 billion in 2020 to $10.6 billion by 2025 at compound annual growth rate (CAGR) of 7.0% for the period of 2020-2025.

Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays

Published - Apr 2013 | Publisher - Carlet Auguste | Code - BIO125A

This study focuses on immunoassays for infectious disease and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.

Recent Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Induced Pluripotent Stem Cells: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO135F

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

Commercial Amino Acids

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO007N

The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Immunoassays: Technologies and Global Markets
Sample Report